Literature DB >> 21367622

Cerebral venous thrombosis in a Mexican multicenter registry of acute cerebrovascular disease: the RENAMEVASC study.

José L Ruiz-Sandoval1, Erwin Chiquete, L Jacqueline Bañuelos-Becerra, Carolina Torres-Anguiano, Christian González-Padilla, Antonio Arauz, Carolina León-Jiménez, Luis M Murillo-Bonilla, Jorge Villarreal-Careaga, Fernando Barinagarrementería, Carlos Cantú-Brito.   

Abstract

BACKGROUND: Cerebral venous thrombosis (CVT) is a rare form of cerebrovascular disease that is usually not mentioned in multicenter registries on all-type acute stroke. We aimed to describe the experience on hospitalized patients with CVT in a Mexican multicenter registry on acute cerebrovascular disease.
METHODS: CVT patients were selected from the RENAMEVASC registry, which was conducted between 2002 and 2004 in 25 Mexican hospitals. Risk factors, neuroimaging, and 30-day outcome as assessed by the modified Rankin scale (mRS) were analyzed.
RESULTS: Among 2000 all-type acute stroke patients, 59 (3%; 95% CI, 2.3-3.8%) had CVT (50 women; female:male ratio, 5:1; median age, 31 years). Puerperium (42%), contraceptive use (18%), and pregnancy (12%) were the main risk factors in women. In 67% of men, CVT was registered as idiopathic, but thrombophilia assessment was suboptimal. Longitudinal superior sinus was the most frequent thrombosis location (78%). Extensive (>5 cm) venous infarction occurred in 36% of patients. Only 81% of patients received anticoagulation since the acute phase, and 3% needed decompressive craniectomy. Mechanical ventilation (13.6%), pneumonia (10.2%) and systemic thromboembolism (8.5%) were the main in-hospital complications. The 30-day case fatality rate was 3% (2 patients; 95% CI, 0.23-12.2%). In a Cox proportional hazards model, only age <40 years was associated with a mRS score of 0 to 2 (functional independence; rate ratio, 3.46; 95% CI, 1.34-8.92).
CONCLUSIONS: The relative frequency of CVT and the associated in-hospital complications were higher than in other registries. Thrombophilia assessment and acute treatment was suboptimal. Young age is the main determinant of a good short-term outcome.
Copyright © 2012 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21367622     DOI: 10.1016/j.jstrokecerebrovasdis.2011.01.001

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  17 in total

Review 1.  Maternal Stroke: an Update.

Authors:  Maria D Zambrano; Eliza C Miller
Journal:  Curr Atheroscler Rep       Date:  2019-06-22       Impact factor: 5.113

Review 2.  Role, Effectiveness, and Outcome of Decompressive Craniectomy for Cerebral Venous and Dural Sinus Thrombosis (CVST): Is Surgery Really an Option?

Authors:  Mohamed Wael F Mohamed; Su Sandi Aung; Nakul Mereddy; Sruthi Priyavadhana Ramanan; Pousette Hamid
Journal:  Cureus       Date:  2020-12-17

Review 3.  Complications Associated with Decompressive Craniectomy: A Systematic Review.

Authors:  David B Kurland; Ariana Khaladj-Ghom; Jesse A Stokum; Brianna Carusillo; Jason K Karimy; Volodymyr Gerzanich; Juan Sahuquillo; J Marc Simard
Journal:  Neurocrit Care       Date:  2015-10       Impact factor: 3.210

4.  [Clinical course of cerebral sinus venous thrombosis. Data from a monocentric cohort study over 15 years].

Authors:  C Geisbüsch; C Lichy; D Richter; C Herweh; W Hacke; S Nagel
Journal:  Nervenarzt       Date:  2014-02       Impact factor: 1.214

Review 5.  Cerebral venous thrombosis.

Authors:  Suzanne M Silvis; Diana Aguiar de Sousa; José M Ferro; Jonathan M Coutinho
Journal:  Nat Rev Neurol       Date:  2017-08-18       Impact factor: 42.937

6.  Evaluation and management of a patient with possible cerebral venous thrombosis.

Authors:  Fernando Barinagarrementeria; Antonio Arauz
Journal:  Neurol Clin Pract       Date:  2014-10

7.  Outcome Prediction in Cerebral Venous Thrombosis: The IN-REvASC Score.

Authors:  Piers Klein; Liqi Shu; Thanh N Nguyen; James E Siegler; Setareh Salehi Omran; Alexis N Simpkins; Mirjam Heldner; Adam de Havenon; Hugo J Aparicio; Mohamad Abdalkader; Marios Psychogios; Maria Cristina Vedovati; Maurizio Paciaroni; Rascha von Martial; David S Liebeskind; Diana Aguiar de Sousa; Jonathan M Coutinho; Shadi Yaghi
Journal:  J Stroke       Date:  2022-09-30       Impact factor: 8.632

8.  MOLECULAR MODELLING, 3D-QSAR, AND DRUG DOCKING STUDIES ON THE ROLE OF NATURAL ANTICOAGULANT COMPOUNDS IN ANTITHROMBOTIC THERAPY.

Authors:  Prathusha Kakarla; Amith R Devireddy; Madhuri A Inupakutika; Upender R Cheeti; Jared T Floyd; Mukherjee M Mun; Raelyn N Vigil; Russell P Hunter; Manuel F Varela
Journal:  Int J Pharm Sci Res       Date:  2014

9.  Endovascular treatment for hemorrhagic cerebral venous sinus thrombosis: experience with 9 cases for 3 years.

Authors:  Shizhong Zhang; Yanyan Hu; Zhen Li; Dezhang Huang; Mingran Zhang; Chenglong Wang; Zhigang Wang
Journal:  Am J Transl Res       Date:  2018-06-15       Impact factor: 4.060

Review 10.  Cerebral sinus venous thrombosis.

Authors:  Hernando Raphael Alvis-Miranda; Sandra Milena Castellar-Leones; Gabriel Alcala-Cerra; Luis Rafael Moscote-Salazar
Journal:  J Neurosci Rural Pract       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.